2542 related articles for article (PubMed ID: 9382741)
1. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
Svensson M; Stockinger B; Wick MJ
J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes.
Pfeifer JD; Wick MJ; Russell DG; Normark SJ; Harding CV
J Immunol; 1992 Oct; 149(8):2576-84. PubMed ID: 1383320
[TBL] [Abstract][Full Text] [Related]
4. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
Harding CV; Song R
J Immunol; 1994 Dec; 153(11):4925-33. PubMed ID: 7963555
[TBL] [Abstract][Full Text] [Related]
5. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells.
Malaviya R; Twesten NJ; Ross EA; Abraham SN; Pfeifer JD
J Immunol; 1996 Feb; 156(4):1490-6. PubMed ID: 8568252
[TBL] [Abstract][Full Text] [Related]
6. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
Matousek MP; Nedrud JG; Harding CV
J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
[TBL] [Abstract][Full Text] [Related]
7. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
Kovacsovics-Bankowski M; Rock KL
Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
Wick MJ; Pfeifer JD
Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
[TBL] [Abstract][Full Text] [Related]
9. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.
Pfeifer JD; Wick MJ; Roberts RL; Findlay K; Normark SJ; Harding CV
Nature; 1993 Jan; 361(6410):359-62. PubMed ID: 7678924
[TBL] [Abstract][Full Text] [Related]
10. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
12. Processing of viable Salmonella typhimurium for presentation of a CD4 T cell epitope from the Salmonella invasion protein C (SipC).
Musson JA; Hayward RD; Delvig AA; Hormaeche CE; Koronakis V; Robinson JH
Eur J Immunol; 2002 Sep; 32(9):2664-71. PubMed ID: 12207351
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
14. Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium.
Wick MJ; Harding CV; Normark SJ; Pfeifer JD
Infect Immun; 1994 Oct; 62(10):4542-8. PubMed ID: 7523293
[TBL] [Abstract][Full Text] [Related]
15. Activation of murine dendritic cells and macrophages induced by Salmonella enterica serovar Typhimurium.
Kalupahana RS; Mastroeni P; Maskell D; Blacklaws BA
Immunology; 2005 Aug; 115(4):462-72. PubMed ID: 16011515
[TBL] [Abstract][Full Text] [Related]
16. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells.
Svensson M; Wick MJ
Eur J Immunol; 1999 Jan; 29(1):180-8. PubMed ID: 9933099
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
[TBL] [Abstract][Full Text] [Related]
18. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
19. Processing of viable group A streptococci leads to major histocompatibility complex class II presentation of T cell epitopes from the major protective antigen.
Rossiter BA; Alfonso C; Kehoe MA; Robinson JH
Eur J Immunol; 1994 May; 24(5):1244-7. PubMed ID: 7514136
[TBL] [Abstract][Full Text] [Related]
20. Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response.
Yrlid U; Svensson M; Johansson C; Wick MJ
FEMS Immunol Med Microbiol; 2000 Apr; 27(4):313-20. PubMed ID: 10727887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
